8 Tumor Models for Evaluation of P450 Gene Therapy In Vivo
P450 prodrug activation-based cancer gene therapy strategies have been developed and show striking effectiveness in both in vitro cell culture and preclinical antitumor animal models (1 ,2 ). In vivo tumor models play an important role in the evaluation of the therapeutic efficacy of these strategies, and complement in vitro approaches (see Chapter 7) designed to evaluate and compare different P450 genes and different P450 gene/prodrug combinations. This chapter describes methods required for in vivo tumor models and their use in evaluating the therapeutic impact of intratumoral P450 gene expression on a tumor’s chemosensitivity to cancer chemotherapeutic agents.
- Establishment and Culture of LeukemiaLymphoma Cell Lines
- Microarray Approaches for Analysis of Tumor Suppressor Gene Function
- The Tissue Microenvironment as an Epigenetic Tumor Modifier
- Detection of Telomerase Activity by PCR-Based Assay
- 细菌和基因工程
- Determining Mutational Status of Immunoglobulin V Genes in Chronic Lymphocytic Leukemia: A Useful Prognostic Indicator
- Strain-Dependent Differences in the Expression of the Oncofetal Protein p65 in Mice Susceptible and Resistant to Chemical Carcin
- Production of Ligand-Specific Mutants Using a Yeast Two-Hybrid Mating Assay
- Tumor-Specific Metastasis to Lung Using Reporter Gene-Tagged Tumor Cells
- Idiotype Gene Rescue in Follicular Lymphoma